Kintara Therapeutics, Inc.
KTRA
NASDAQ
| Weiss Ratings | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.67 | |||
| Price History | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 15.87% | |||
| 30-Day Total Return | 23.86% | |||
| 60-Day Total Return | -0.83% | |||
| 90-Day Total Return | 12.77% | |||
| Year to Date Total Return | 35.56% | |||
| 1-Year Total Return | -94.71% | |||
| 2-Year Total Return | -95.70% | |||
| 3-Year Total Return | -99.49% | |||
| 5-Year Total Return | -99.11% | |||
| 52-Week High % Change | -95.30% | |||
| 52-Week Low % Change | 165.93% | |||
| Price | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $160.51 | |||
| 52-Week Low Price | $2.84 | |||
| 52-Week Low Price (Date) | Mar 12, 2024 | |||
| 52-Week High Price (Date) | Oct 19, 2023 | |||
| Valuation | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 11.61M | |||
| Enterprise Value | 16.95M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -75.24 | |||
| Earnings Per Share Growth | -77.15% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -1.83 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $7.54 | |||
| Enterprise Value/EBITDA (TTM) | -2.02 | |||
| Enterprise Value/EBIT | -2.01 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.57M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -0.07% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 858 350 4364 | |||
| Address | 9920 Pacific Heights Blvd San Diego, CA 92121 | |||
| Website | www.kintara.com | |||
| Country | United States | |||
| Year Founded | 2009 | |||
| Profitability | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -103.76% | |||
| Return on Equity | -- | |||
| Income Statement | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -8.40M | |||
| EBIT (TTM) | -8.45M | |||
| Net Income (TTM) | -8.32M | |||
| Net Income Avl. to Common (TTM) | -8.33M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 30.31% | |||
| EPS Diluted (TTM) | -75.24 | |||
| EPS Diluted Growth (Q YOY) | 97.86% | |||
| Balance Sheet | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 4.91M | |||
| Cash Per Share (Q) | $3.12 | |||
| Total Current Assets (Q) | 5.53M | |||
| Total Preferred Equity (Q) | 10.25 | |||
| Total Equity (Q) | 3.76M | |||
| Current Ratio (Q) | 2.447 | |||
| Book Value Per Share (Q) | -$4.11 | |||
| Total Assets (Q) | 6.20M | |||
| Total Current Liabilities (Q) | 2.26M | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 2.45M | |||
| Total Common Equity (Q) | -6.50M | |||
| Cash Flow | KTRA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -20.00K | |||
| Cash from Financing (TTM) | 10.57M | |||
| Net Change in Cash (TTM) | 3.37M | |||
| Levered Free Cash Flow (TTM) | -4.09M | |||
| Cash from Operations (TTM) | -7.18M | |||
